Delivery Order SPE2DB20D2104-SPE2DB24FV09H
Award Date
7/9/24
Potential Completion Date
7/10/24
Potential Value
$8.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Otezla 30 mg tablets in quantities of 60 to the Defense Logistics Agency (DLA). The $35,497.88 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The contract has an ultimate completion date of January 4, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $10,633.20, was made to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,842.24 and a completion date of June 9, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is a subsidiary...
This federal contract award is for the delivery of Otezla 30 mg tablets in quantities of 60 per prescription. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 with the Defense Logistics Agency (DLA) Troop Support Medical, which runs through November 2026. This IDC enables the DLA to...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $11,238.27 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The $7,407.24 delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. AmerisourceBergen is a subsidiary of the parent company Cencora, Inc., which also does business as AmerisourceBergen. The contract has an ultimate completion date of January 26, 2023 and utilizes a firm fixed price pricing structure....
This federal contract award is for the delivery of Otezla 30 mg tablets to support the Defense Logistics Agency (DLA) Troop Support Medical program. The $21,734.96 firm fixed price delivery order was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA to provide a comprehensive range of medical commodities. This contract does not utilize a small business set-aside. Amerisourcebergen,...
This federal contract award is for the delivery of OTEZLA 30 MG TABLET 60S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, and is valued at $2,230.72. The contract is a Firm Fixed Price Delivery Order with a completion date of June 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $14,955.31 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2022, with a completion date of May 23, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of OTEZLA 30 MG TABLET 60S. The contract, valued at $11,751.67, is a delivery order with a firm fixed price. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of February 28, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds an Indefinite Delivery Contract (IDC)...